Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

GNOMvsPTHETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
+3.8%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-0.7%

Global X Genomics & Biotechnology ETF (GNOM) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. GNOM's top 3 sector exposures are Healthcare and Industrials. In contrast, PTH's top sector exposures are Healthcare  GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.72% for PTH. GNOM is up 21.83% year-to-date (YTD) with +$18M in YTD flows. PTH performs worse with 19.17% YTD performance, and +$93M in YTD flows. Run a side-by-side ETF comparison of GNOM and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs PTH performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

0 M20 M40 M60 M80 M100 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
PTH
-2.19%-0.69%
+22.58%+17.11%
+21.83%+19.17%
+58.30%+60.51%
+14.80%+57.34%
-38.54%+10.70%
Flows
GNOM
PTH
+$7M+$106M
+$19M+$99M
+$18M+$93M
+$13M+$99M
-$95M+$30M
-$862K-$185M
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
PTH
+28.16%+29.64%
+26.78%+24.90%
+29.11%+25.71%
+33.32%+25.60%
Max drawdown
GNOM
PTH
-8.57%-8.31%
-18.16%-11.91%
-43.10%-27.71%
-72.01%-50.10%
Max drawdown duration
GNOM
PTH
24d41d
145d140d
674d353d
1792d1756d
Trading data

Create an account to view trading data

Join for free
GNOM
PTH
Last sale
7/31/2026 at 1:30 PM
$54.17
$58.10
Previous close
07/30/2026
$55.39
$59.27
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
GNOM
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
GNOM
PTH
Last price
$54.17
$58.10
1D performance
-2.21%
-1.97%
AuM$81.18 M$239.95 M
E/R0.5%0.72%
Characteristics
GNOM
PTH
Management strategyPassivePassive
ProviderGlobal XInvesco
BenchmarkSolactive Genomics IndexDorsey Wright Healthcare Technical Leaders Index
N° of holdings5057
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
84.1%
Other
15.9%
PTH
USA
92.25%
Other
7.75%

Sectors

GNOM
Healthcare
99.75%
Other
0.25%
PTH
Healthcare
100%
Other
0%
Advertisement

Diversification

GNOM

Total weight of top 15 holdings out of 15

61.22%
PTH

Total weight of top 15 holdings out of 15

43.88%

Top 15 holdings

Data as of June 30, 2026
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
PTH
Roivant Sciences Ltd.
4.95%
Praxis Precision Medicines, Inc.
4.66%
Tango Therapeutics, Inc.
3.70%
SELLAS Life Sciences Group, Inc.
3.36%
United Therapeutics Corp.
2.91%
Tenet Healthcare Corp.
2.89%
Axsome Therapeutics, Inc.
2.74%
BrightSpring Health Services, Inc.
2.54%
Liquidia Corp.
2.52%
Moderna, Inc.
2.49%
Ionis Pharmaceuticals, Inc.
2.30%
Erasca, Inc.
2.29%
HCA Healthcare, Inc.
2.23%
Twist Bioscience Corp.
2.21%
Protagonist Therapeutics, Inc.
2.08%
Frequently asked questions about GNOM and PTH

How have the GNOM and PTH ETFs performed in 2026?

As of July 30, 2026, GNOM is up 21.83% year-to-date (YTD), while PTH has returned 19.17%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or PTH?

Year-to-date, the GNOM ETF saw +$18M in flows, compared to +$93M for PTH.

Which ETF is more volatile: GNOM or PTH?

Over the past year, GNOM had a volatility of 26.78%, while PTH experienced 24.9%.

Which ETF is bigger: GNOM or PTH?

As of July 30, 2026, GNOM holds $81.18 M in assets under management (AUM), while PTH manages $239.95 M.

What sectors do the GNOM and PTH ETFs invest in?

GNOM leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.

What are the top holdings of the GNOM ETF and PTH ETF?

GNOM top holdings include Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc.. PTH holds in its top three: Roivant Sciences Ltd., Praxis Precision Medicines, Inc. and Tango Therapeutics, Inc..

Which ETF is more diversified: GNOM or PTH?

GNOM holds 50 securities with 61.22% of its assets in the top 15. PTH has 57 securities and a top 15 weight of 43.88%.

Advertisement
Latest news about GNOM & PTH
Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up